The federal agency tasked with studying ways to improve America’s outstandingly poor healthcare system is “on the brink,” experts warn. The Trump administration has cut its staff by 75 percent, canceled its grants en masse, and is refusing to spend tens of millions of dollars appropriated by Congress.

Whether the agency “will survive the second Trump administration is an open question,” health policy experts Aaron Carroll and David Atkins wrote in an opinion piece published today in the Annals of Internal Medicine.